These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23032887)

  • 81. In regards to Orlandi et al HED-19-0487.
    Dagan R; Bryant C
    Head Neck; 2019 Oct; 41(10):3736. PubMed ID: 31313872
    [No Abstract]   [Full Text] [Related]  

  • 82. Second cancer risk.
    Green S; Jones B
    Br J Radiol; 2005 May; 78(929):469. PubMed ID: 15845947
    [No Abstract]   [Full Text] [Related]  

  • 83. A Clarion Call for Large-Scale Collaborative Studies of Pediatric Proton Therapy.
    Berrington de Gonzalez A; Vikram B; Buchsbaum JC; de Vathaire F; Dörr W; Hass-Kogan D; Langendijk JA; Mahajan A; Newhauser W; Ottolenghi A; Ronckers C; Schulte R; Walsh L; Yock TI; Kleinerman RA
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):980-981. PubMed ID: 28721911
    [No Abstract]   [Full Text] [Related]  

  • 84. [Prevention of risk of second primary neoplasms].
    Warnet S
    Rev Infirm; 2014 Apr; (200):8. PubMed ID: 24881229
    [No Abstract]   [Full Text] [Related]  

  • 85. "Cancer risk after breast proton therapy considering physiological and radiobiological uncertainties" by Raptis et al. (Physica Medica 76 (2020) 1-6).
    Paganetti H
    Phys Med; 2020 Dec; 80():274-276. PubMed ID: 33227626
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Avoiding chemotherapy related late effects in children with curable tumours.
    Pinkerton CR
    Arch Dis Child; 1992 Sep; 67(9):1116-9. PubMed ID: 1417057
    [No Abstract]   [Full Text] [Related]  

  • 87. Childhood cancers' improved survival rates can exact a price in late effects of therapy.
    Raymond CA
    JAMA; 1988 Dec; 260(23):3400, 3405. PubMed ID: 3210273
    [No Abstract]   [Full Text] [Related]  

  • 88. [Late effects of childhood cancer treatment].
    Lopes LF; Camargo Bd; Bianchi A
    Rev Assoc Med Bras (1992); 2000; 46(3):277-84. PubMed ID: 11070520
    [No Abstract]   [Full Text] [Related]  

  • 89. [Proton therapy centres opened; what next?].
    Boersma LJ; van Vulpen M; Rasch CRN; Langendijk JLA
    Ned Tijdschr Geneeskd; 2018 May; 162():. PubMed ID: 30040254
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Therapy-related second malignancies. Proceedings of a symposium. Boston, January 1992.
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):325-493. PubMed ID: 8468268
    [No Abstract]   [Full Text] [Related]  

  • 91. Secondary malignancy after radiotherapy: not always a secondary concern.
    Reddy VK; Vapiwala N
    Nat Rev Urol; 2021 Sep; 18(9):513-514. PubMed ID: 34083799
    [No Abstract]   [Full Text] [Related]  

  • 92. Study identifies risk factors that may lead to secondary cancers.
    Fillon M
    CA Cancer J Clin; 2024; 74(2):120-122. PubMed ID: 38481043
    [No Abstract]   [Full Text] [Related]  

  • 93. May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk?
    Francolini G; Ciccone LP; Di Cataldo V; Detti B; Simontacchi G; Loi M; Mangoni M; Desideri I; Meattini I; Livi L
    J Clin Oncol; 2021 Nov; 39(33):3762-3763. PubMed ID: 34534000
    [No Abstract]   [Full Text] [Related]  

  • 94. Uncovering causal clues in the development of second primary cancers.
    Yi H; Ji J
    Lancet Oncol; 2024 Mar; 25(3):e97. PubMed ID: 38423065
    [No Abstract]   [Full Text] [Related]  

  • 95. Radiation-Induced Malignancies Making Radiotherapy a "Two-Edged Sword": A Review of Literature.
    Singh GK; Yadav V; Singh P; Bhowmik KT
    World J Oncol; 2017 Feb; 8(1):1-6. PubMed ID: 28983377
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [What can be learned from cancers occurring after therapeutic radiation? Proceedings of a meeting of the French Society of Radioprotection. Paris, 27 March 1992].
    Bull Cancer; 1992; 79(4):369-400. PubMed ID: 1421695
    [No Abstract]   [Full Text] [Related]  

  • 97. Invited Commentary: Secondary Malignancies in Patients Treated with Radiation Therapy.
    Shapiro A
    Radiographics; 2021; 41(3):E90-E91. PubMed ID: 33900119
    [No Abstract]   [Full Text] [Related]  

  • 98. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
    Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Incidence of second malignancies among patients treated with proton versus photon radiation.
    Chung CS; Yock TI; Nelson K; Xu Y; Keating NL; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):46-52. PubMed ID: 23778197
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A perspective on tumor radiation resistance following high-LET radiation treatment.
    Rajpurohit YS; Sharma DK; Lal M; Soni I
    J Cancer Res Clin Oncol; 2024 May; 150(5):226. PubMed ID: 38696003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.